Compass Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2020 | $111.8K | $3.7K | $3.7K |
| Jun 2020 | $17.2M | $70.4M | $65.4M |
| Sep 2020 | $13.4M | $60.7M | $55.5M |
| Dec 2020 | $12.0M | $51.9M | $47.1M |
| Mar 2021 | $14.7M | $48.2M | $39.7M |
| Jun 2021 | $12.0M | $40.9M | $31.2M |
| Sep 2021 | $11.0M | $34.9M | $25.5M |
| Dec 2021 | $13.7M | $153.8M | $144.5M |
| Mar 2022 | $12.1M | $146.6M | $136.4M |
| Jun 2022 | $13.3M | $140.3M | $26.2M |
| Sep 2022 | $11.7M | $127.8M | $16.5M |
| Dec 2022 | $18.0M | $199.6M | $34.9M |
| Mar 2023 | $12.7M | $188.0M | $27.0M |
| Jun 2023 | $10.9M | $179.2M | $19.3M |
| Sep 2023 | $10.0M | $170.0M | $30.4M |
| Dec 2023 | $8.3M | $156.9M | $24.2M |
| Mar 2024 | $4.1M | $161.1M | $43.5M |
| Jun 2024 | $9.5M | $155.6M | $19.4M |
| Sep 2024 | $10.8M | $149.2M | $19.4M |
| Dec 2024 | $15.2M | $140.4M | $43.5M |
| Mar 2025 | $21.2M | $131.5M | $41.0M |
| Jun 2025 | $23.5M | $116.7M | $22.9M |
| Sep 2025 | $21.6M | $231.3M | $46.2M |
| Dec 2025 | $22.8M | $219.6M | $30.6M |
| Mar 2026 | $18.7M | $205.2M | $55.2M |
| Jun 2026 | $24.1M | $190.2M | $35.5M |